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BACKGROUND: Delay in leprosy diagnosis and treatment causes disabilities due to nerve damage, 
immunological reactions and bacillary infiltration. Leprosy disability leads not only to physical 
dysfunction and activity limitation but also disrupts social interaction of affected individuals by creating 
stigma and discrimination. This study was aimed at assessing leprosy disability status in patients 
registered at All African TB and Leprosy Rehabilitation and Training Centre.  
METHODS: Medical records of leprosy patients registered from September 11, 2010 to September 10, 
2013 G.C were reviewed. Prevalence of disability calculated, bivariate and multiple logistic regressions 
were used to determine crude and adjusted odds ratios with 95% confidence interval. 
RESULTS: The overall prevalence of disability was found to be 65.9% from all categories of patients 
(40.2% Grade I and 25.7% Grade II). The Prevalence among the new category was 62.8% (39.1% Grade 
1 and 23.7% Grade 2). Those ageed above 30 years, with duration of symptoms 6-12 months and above 
24 months, with sensory loss, nerve damage and reversal reaction were more likely to develop disability.  
CONCLUSION: In this study the prevalence of disability, both Grade I and II, is very high. Disability 
was associated with age, duration of symptom, sensory loss, signs of nerve damage and reversal reaction. 
These risk factors indicate the existence of delay in diagnosis and treatment of leprosy cases.  Therefore, 
the national leprosy control program should investigate leprosy case detection and diagnosis system in 
the country and work on improving early case detection and prevention of disability. 





Leprosy is a chronic disease caused by 
Mycobacterium leprae. The causative agent 
affects peripheral nerves and causes damage by 
binding with Schwann cells which are important 
for conducting nerve impulses (1, 2). The 
interaction of M. leprae with Schwann cells causes 
irreversible loss of peripheral nerve tissue 
followed by disabilities (3). In some case, nerve 
damage occurs without skin lesions which make 
diagnosis difficult leading to further damage.  
Leprosy related disability is preventable if 
diagnosed early; but many cases are diagnosed 
late with disability of significant physical 
impairment. The damage is not limited to the 
physical inability but also creates a negative image 
leading to discrimination and social stigma against 
the affected individuals and their families (4).   
The burden of leprosy can be measured in 
terms of the occurrence of reported new cases, or 
of the number of cases registered for treatment, or 
the number of cases with disabilities. In Ethiopia,  
a total of 4374 (4028 MB and 346 PB) new
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leprosy cases was reported in 2013 which is 
lower than the report  in the previous year. 
Among these, 4374, 466(10.65%) were 
children and 361(8.25%) of new cases of 
leprosy had disability grade II (5). 
The major risk factors known for leprosy 
disability and physical deformity are delay in 
diagnosis, and delay in provision of proper care 
for the disease. The other known risk factors are 
multiple nerve enlargements, the type of 
leprosy(pauci or multi bacillary),  smear result and 
age (6-8). 
The World Health Organization’s 2011-2015 
global strategy for leprosy control focuses on 
reducing the rate of new leprosy cases with grade 
II disabilities per 100,000 people by at least 35% 
at the end of 2015 taking 2010’s occurrence as 
reference (9).  To achieve this goal, the measures 
to be taken are to detect and treat the disease early 
before nerve damages occur. Early diagnosis of 
grade I disability is also an important measure to 
prevent development of disability to the second 
stage which has serious physical and 
psychological damage to the patient.  This study 
aimed at assessing the prevalence of disability and 
associated factors among registered leprosy 
patients in All African TB and Leprosy 
Rehabilitation and Training Centre, Addis Ababa.  
 
METHODS  
Study setting: The study was conducted in All 
African TB and Leprosy Rehabilitation and 
Training Center (ALERT) in Addis Ababa, the 
capital city of Ethiopia. The center currently 
serves as a general teaching hospital, has 240 beds 
and consists of dermatology, ophthalmology, 
surgery and orthopedic departments. It also has an 
orthopedic workshop and a rehabilitation program. 
The leprosy treatment unit on the average sees 
around 470 patients annually. It provides service 
to  patients coming  from all regions of the 
country.  
Study design: A cross sectional retrospective 
record review was used to gather the data. Medical 
records of leprosy patients registered from 
September 11, 2010 to September 10, 2013 were 
reviewed. 
Sample size and sampling procedure: Sample 
size was calculated using single population 
proportion formula with the following 
assumptions:  marginal error (d) of 4% with 95% 
confidence interval and prevalence of disability 
31%. The calculated sample size was 513. 
Systematic sampling was used to select data from 
registers. First, the interval (k value) was calculate 
using the formula (K=1417/513). Then, starting 
point was selected by using simple random 
sampling method from the first kth value and data 
were reviewed for every 3rd patient.  
Data Collection Procedure: Data were collected 
by 2 trained nurses, who were working in leprosy 
treatment unit. Predesigned data abstraction form 
was used for data collection.  
Variables: The dependent variable was disability 
(no disability or grade I or II disability).  The 
independent variables were Age, Sex, Address, 
Type of Leprosy (MB,PB), Number of Skin 
Lesion, Smear Result, Category of Treatment 
(New, Relapse, Defaulter and Others), Duration of 
Symptom, Thickened Nerve, Reversal Reaction, 
Erythema Nodosum Leprosum (ENL),Care Given 
to the Patient while on MDT, Initiation of Steroid 
Treatment and the Chief Complaints.  
Operational Definitions 
DG 0 - no disability caused by leprosy in eyes, 
hands and feet  
DG 1 - Eye problem caused by leprosy, but vision 
is not severely affected (equals 6/60 or better; 
fingers can be counted at six meters apart); loss of 
sensibility in hands or feet.  
DG 2 - Eyes: lagophthalmos and/or ectropion; 
trichiasis; visual impairment (fingers not counted 
at 6m) Hands and feet: with visible damage i.e. 
claw hands, foot drop, reabsorption of fingers or 
toes, wounds) (10, 11). 
Pauci-bacillary- five or fewer lesions with no 
bacteria detected in the skin smear (sample    taken 
from the area) 
 Multi-bacillary- More than five lesions or a 
bacterium is detected in the skin smear, or both. 
New case- A patient with MB or PB leprosy who 
has never had treatment for leprosy before. 
Relapse: a patient declared “treatment completed” 
after a course of MDT but who reports back to the 
HF and found to have active leprosy 
Return after default- an MB or PB who returns 
for treatment after having missed more than 3 
months “dose of MDT (both cumulative and 
consecutively)” 
Transfer in- a patient received from another HF 
to continue treatment 




Others- any leprosy patient requiring 
chemotherapy who does not fit in any of the above 
mentioned categories, including patient with  
relapse after treatment with dapsone mono therapy 
in the past (12) 
Data management and analysis: The collected 
data were checked by the principal investigator 
(PI) on daily basis for any incompleteness and/or 
inconsistency. When any incompleteness and/or 
inconsistency appeared, corrections were made by 
re-checking them back against the records. Data 
entry was done using EPI info. Then, the data 
were exported to SPSS statistical software for 
analysis.  
  Frequencies were used to calculate the 
prevalence of disability; bivariate and multiple 
logistic regression were done to calculate the 
crude and adjusted odds ratios with the 95% 
confidence interval.  
Ethics: Ethical approval was obtained from 
ALERT hospital IRB.  Patients’ names were not 





Socio-demographic characteristics: A total of 
513 complete records were reviewed. Patients who 
visited the hospital for 3 years (Sep 11, 2010 to 
Sep 10, 2013) were included. Out of those 
involved in this study, 98.1% reported by 
themselves; of these, 328(63.9%) were male and 
185(36.1%) were females patients. Twenty-five 
(4.9%) of the leprosy patients were aged less than 
or equal to 14 years. Two hundred and twenty-five 
(43.9%) were aged 15 to 30 years. One hundred 
and seventy-two (33.5%) were in the age group of 
30-50. The remaining 91 (17.7%) were above 50 
years old (Table 1). The majority of the patients 
came from outside Addis Ababa: 36. 6% from 
Oromia Region, 32.4% from Amhara Region and 
only 16% were from Addis Ababa (Table 1).  
Clinical characteristics of the patients: Three 
hundred and seventy-nine (73.9%) of the patients 
were newly diagnosed cases of leprosy, 11(2.1%) 
were returnees after default, 35(6.8%) were 
relapse and the remaining 88(17.2%) were in other 
categories (Table 1).  Almost all of the patients 
were multi-bacillary (MB) leprosy cases, 
509/513(99.2%). Loss of sensation was reported in 
305(59.5%), 294(57.3%) of the leprosy patients 
were started on steroid treatment. Among the 
patients who had reversal reaction, 89.8% were 
started on steroid treatment. In addition, there 
were 80 leprosy patients from the total who had 
Erythema Nodosum Leprosum (ENL) who were 
on steroid treatment (Table 1). Prevalence of 
disability and factors associated with aisability 
From the total of 513 patients, 338(65.9%) had 
disability.  Two hundred and six (40.2%) had 
disability grade I and 132 (25.7%) had grade II 
disability (Figure 1). Prevalence among the new 





Figure 1: Disability status of leprosy patients 
registered from September 11, 2010 to September 10, 
2013, ALERT Hospital, Addis Ababa, Ethiopia 
 
DG1: Disability grade I 
DG2: Disability grade II 














Table 1: Socio-demographic and clinical characteristics of leprosy patients registered in ALERT Hospital 
from September 11, 2010 to September 10, 2013, Addis Ababa, Ethiopia 
 
 
Variables  Characteristics Frequency  Percent 
Sex Male 328 63.9 
  Female 185 36.1 
Age ≤ 14 25 4.9 
  ≥15 to 30 225 43.9 
  ≥31 to 50 172 33.5 
  ≥51 91 17.7 
Address(Region) Addis Ababa 92 17.9 
  Amhara region 166 32.4 
  Oromiya region 188 36.6 
  SNNP region 49 9.6 
  Others 18 3.5  
Method of case finding Voluntary (passive) 503 98.1 
  Contact Tracing 10 1.9 
Duration of symptom ≤6 Months 138 26.9 
  6 to 12 months 150 29.2 
  12 to 24 Months 81 15.8 
  >24 Months 144 28.1 
Type of leprosy Multi Bacillary 509 99.2 
  Pauci Bacillary 4 0.8 
Treatment category New 379 73.9 
  Defaulter 11 2.1 
  Relapse 35 6.8 
  Others 88 17.2 
Number of skin lesion No skin lesion 128 25 
  1 to 5 25 4.9 
  ≥6 360 70.2 
Sensory loss Present 305 59.5 
  Absent 208 40.5 
Smear result Not Done 14 2.7 
  Smear Positive 213 41.5 
  Negative 286 55.8 
Thickened nerve Yes 316 61.6 
  No 197 38.4 
Steroid started Yes 294 57.3 
  No 219 42.7 
Reversal Reaction(RR) Present 147 28.7 
  Absent 366 71.3 
ENL Present 93 18.1 
  Absent 420 81.9 









Table 2 gives details on factors associated with 
disability (either grade I or grade II).  All the 
variables which are associated with disability in 
the bivariate analysis, except treatment category, 
maintained their association in the multiple 
logistic regression analysis. Age greater than 30: 
those in age group 30-50 years AOR 3.98 CI(1.36-
11.65), p value 0.011 and those 50+ years AOR 
6.61 CI (2.04-21.33), p 0.002. Patients with  
duration of symptom 6 to 12 months  and those 
greater than 24 months were also more likely to 
develop disability, AOR 2.13 CI(1.14-3.96), p 
0.017 and >24 months AOR 2.491 CI(1.31-4.72),p 
0.005. Those who presented with sensory loss 
were also more likely to have disability, AOR 1.72 
CI (1.07-2.77), p 0.036. Sign of nerve damage and 
reversal reaction were also associated with higher 
disability rate, AOR and 95% CI: 13.10 CI (8.07-
21.25), p 0.000, 1.85 CI(1.03-3.33), p 0.038,  
respectively.  
 
DISCUSSION   
 
This study revealed that 65.9% of the leprosy 
patients studied had disability Grade I or II.  
Among those with disability, 40.2% had grade I 
and 25.7% had grade II disabilities. Age, duration 
of symptoms, sensory loss and nerve damage and 
reversal reaction are the factors found to be 
associated with disability.  
The prevalence of disability in this study is 
very high as more than half of the patients 
presented with one kind of disability. This high 
prevalence of disability indicates the existence of 
problems in terms of early case finding and 
treatment. If patients had chance of being 
diagnosed early, they could have been cured from 
the disease before any of the complications 
appeared.   Most of the patents in this study were 
from outside Addis Ababa. This could be because 
of misdiagnosis of patients in the peripheral health 
facilities, or patients may not have any knowledge 
to seek health care at early stage; by the time they 
develop disability they usually prefer to go far  
from their residence to seek medical help as they 
do not want to be recognized in their communities 
because of the stigma related with the disease.  
Nearly 5% of the patients were aged less than 
14 showing that transmission is still going on in 
the community. This high prevalnec in younger 
age group calls for more vigorous means of case 
detection like active search for cases especially in 
communities known to be leprosy endemic. 
The prevalence of disability was found to be 
increasing as age increases. This also suggests that 
patients may have had symptoms for a long time 
without being diagnosed or treated. For patients in 
the age group greater or equal to 30, disability was 
high; as people in this age group are engaged in 
physical work, they are vulnerable to different 
kinds of injuries.  It is also possible that the older 
age groups may have had the disease for a long 
time without suspecting it to be leprosy; the only 
time they might have had suspicion would have 
been when they saw the damage in their body.   
Almost all of the factors found to be associated 
with disability are related to prolonged duration of 
symptoms or late diagnosis of patients. The longer 
the duration of symptoms the higher the likelihood 
of developing nerve damage and sensory loss, 
both of which subsequently lead to disability.   
Among newly detected cases, the prevalence 
of grade II disability was 23.7%. In African 
Region, the prevalence of grade II disability 
ranges from 2.1% in Comoros to 33.2% in 
Burknia Faso (4). In some countries of Asia, a 
higher rate of grades I and II disabilities have been 
reported (48.7% grade I and 28.0% grade II in 
Indonesia). Report from the Federal Ministry of 
Health of Ethiopia shows relatively lower rate of 
grade I and II disabilities, 22% and 9%, 
respectively.  These figures are different from 
what we have found (39.1% and 23.7%) and could 
be explained by the fact that the patients in our 
study were different as most of them came to this 
tertiary level hospital very late after the diseases 














                     Table 2: Factors Associated with disability in leprosy patients registered in ALERT Hospital from September 11, 2010 to September 10, 2013, Addis Ababa, Ethiopia 
 
 
 Characteristics Having Not Having COR  &  95%CI   AOR 
disability disability Sig 
Age ≤14 9(36%) 16 (64%) 1.00   1.00 
 15 to 30 131(58.2%) 94 (41.77%) 2.47(1.05 -5.84) 0.177 2.04(0.72-5.79) 
  31 to 50 124(71.1%) 48 (27.9%) 4.59(1.90-11.09) 0.011 3.98(1.36-11.64) 
 ≥51 74(81.3%) 17 (18.7%) 7.73(2.92-20.45) 0.002 6.60(2.04-21.33) 
Duration  ≤6 Months 60(43.5%) 78(56.5%) 1.00   1.00 
of symptom   
 6 to 11 months 50(33.3%) 100(66.7%) 1.53(0.95-2.48) 0.017 2.13(1.14-3.96) 
  12 to 24 Months 27(33.3%) 54(66.7%) 1.53(0.86-2.72) 0.231 1.55(0.75-3.18) 
 >24 Months 38(26.4%) 106(73.6%) 2.14(1.30-3.54) 0.005 2.49(1.31-4.72) 
Category of New 238(62.8%) 141 (37.2%) 0.46(0.26-0.80)   0.51(0.25-1.04) 
 Treatment 0.64 
 Defaulter 6(54.5%) 5 (45.5%) 0.33(0.09-1.20) 0.21 0.36(0.07-1.79) 
  Relapse 25(71.4%) 10 (28.6%) 0.68(0.28-1.68) 0.88 0.92(0.29-2.84) 
 Others 69(78.4%) 19 (21.6%) 1.00  1.00 
Sensory Loss Present 221(72.5%) 84 (27.5%) 2.04(1.41-2.96) 0.036 1.72(1.06-2.77) 
 Absent 117(56.3%) 91 (43.8%) 1.00  1.00 
Sign of nerve Yes 273(86.7) 42(13.3%) 13.30(8.56-20.64)   13.09(8.07-21.25) 
 Damage 0.000 
 No 65(32.8%) 133(67.2%) 1.00  1.00 
RR Present 120(81.6%) 27(18.4%) 3.01(1.89-4.81) 0.038 1.85(1.03-3.33) 
  Absent 218(59.6%) 148(40.8%) 1.00   1.00 




With regard to the risk factors, age is one of the 
factors found associated with disability. The risk 
of nerve impairment which leads to disability 
increases with age; this has also been reported by 
other studies (13-15). Our study also confirms 
higher prevalence of disability with increasing 
age. The risk of development of disability was 
high in those patients who had symptom for more 
than 24 months. This is also consistent with the 
results of previous studies which showed a higher 
risk of disability in patients who had symptom for 
6 to 12 month and more than 24 months (13).  
Patients who had RR had associated disability; 
this finding is also consistent with previous studies 
(13, 16).     
This study has limitation as it involved only 
one tertiary level hospital. More severe cases are 
likely to be seen here which may have 
overestimated the prevalence of disability.   
This study showed that disability is very high 
among registered leprosy patients. The rate of 
disability in newly registered leprosy cases was 
also very high.  Grade II disability is much higher 
than the acceptable percentage (which is below 
10%). This implies that action is needed to 
improve early case detection and prevention of 
disability. The risk factors identified in this study, 
nerve damage and sensory loss, are results of 
prolonged duration of illness and delay in 
diagnosis. Therefore, it is important to urgently 
evaluate the case detection mechanism and the 
diagnosis system.  It is also important to assess the 
diagnostic suspicion of the first line health 
workers in the periphery, and the public awareness 
on the   symptoms and signs of leprosy in order to 




We would like to thank Addis Continental 
Institute of Public Health, University of Gonder, 
and ALERT Hospital for their support in the 
research work. Our special acknowledgement goes 
to ALERT Hospital staff especially to those in the 




TS was the principal investigator responsible for 
designing and conduction the study. Further, she 
was involved in analyzing the data and writing up 
the manuscript.  MD participated in designing the 
study, data analysis and writeup of the manuscript.  
YM was involved in designing, data analysis and 
writeup of the manuscript.  All authors read and 




1. Bhat RM, Prakash C. Leprosy: an overview of 
pathophysiology. Interdisciplinary 
perspectives on infectious diseases, 
2012;2012:181089. Epub 2012/09/19. 
2. Shetty VP, Dosh RP. Detection and 
Classification of Leprosy: Future Needs and 
Strategies. Indian J Lepr, 2008;80 : 139-147. 
3. Spierings E, De Boer T, Zulianello L, 
Ottenhoff TH. Novel mechanisms in the 
immunopathogenesis of leprosy nerve 
damage: the role of Schwann cells, T cells and 
Mycobacterium leprae. Immunology and cell 
biology, 2000;78(4):349-55. Epub 2000/08/18.    
4. van Brakel WH, Sihombing B, Djarir H, Beise 
K, Kusumawardhani L, Yulihane R, et al. 
Disability in people affected by leprosy: the 
role of impairment, activity, social 
participation, stigma and discrimination. 
Global health action, 2012;5. Epub 
2012/07/25. doi:  10.3402/gha.v5i0.18394. 
5. Global leprosy update, 2013; reducing disease 
burden. Releve epidemiologique 
hebdomadaire/Section d'hygiene du 
Secretariat de la Societe des Nations Weekly 
epidemiological record / Health Section of the 
Secretariat of the League of Nations. 
2014;89(36):389-400. Epub 2014/09/10. 
6. Kar BR, and Job CK, Visible Deformity in 
Childhood Leprosy A 10-Year Study, journal 
of leprosy and Other Mycobacterial  
Diseases,dec, 2005;73(4):243-8. 
7. Sarkar J, Dasgupta A, Dutt D. Disability 
among new leprosy patients, an issue of 
concern: An institution based study in an 
endemic district for leprosy in the state of 
West Bengal, India. Indian J Dermatol 
Venereol Leprol, 2012;78:328-34. 
8. Smith WCS, Nicholls PG, Das L, Barkataki P, 
Suneetha S, Predicting Neuropathy and 
Reactions in Leprosy at Diagnosis and Before 
Incident Event Results from the INFIR Cohort 
Study. PLoS Negl Trop Dis .2009,3(8):e500.  
9. WHO EXECUTIVE BOARD, Leprosy 
(Hansen disease),WHO EB128/16128th 
Session Provisional agenda item 4.13 , 2010. 





10. Brandsma JW, Van Brakel WH. WHO 
disability grading: operational definitions. 
Leprosy review, 2003;74(4):366-73. Epub 
2004/01/31. 
11. Raposo MT, Caminha AV, Heukelbach J, 
Sanchez-Gonzalez MA, de Medeiros JL, 
Nemes MI. Assessment of physical 
impairments in leprosy patients: a comparison 
between the world health organization (who) 
disability grade and the Eye-Hand-Foot score. 
Revista do Instituto de Medicina Tropical de 
Sao Paulo, 2011;53(2):77-81. Epub 
2011/05/04. 
12. Department of health and families Center for 
disease control, guidelines for control of 
leprosy in the northern territory, 2010 third 
edition-www.nt.gov.au/health. 
13. Moschioni C, Antunes CMdF, Grossi MAF, 
Lambertucci JR. Risk factors for physical 
disability at diagnosis of 19,283 new cases of 
leprosy. Revista da Sociedade Brasileira de 
Medicina Tropical, 2010;43:19-22. 
14. Moet FJ, Pahan D, Schuring RP, Oskam L, 
Richardus JH. Physical distance, genetic 
relationship, age, and leprosy classification are 
independent risk factors for leprosy in 
contacts of patients with leprosy. The Journal 
of infectious diseases, 2006;193(3):346-53. 
Epub 2006/01/03. 
15. Ranque B, Nguyen VT, Vu HT, Nguyen TH, 
Nguyen NB, Pham XK, et al. Age is an 
important risk factor for onset and sequelae of 
reversal reactions in Vietnamese patients with 
leprosy. Clinical infectious diseases: an 
official publication of the Infectious Diseases 
Society of America. 2007;44(1):33-40. Epub 
2006/12/05. 
16. Motta AC, Pereira KJ, Tarquinio DC, Vieira 
MB, Miyake K, Foss NT. Leprosy reactions: 
coinfections as a possible risk factor. Clinics 
(Sao Paulo). 2012;67(10):1145-8. Epub 
2012/10/17. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
